Canada - English - Health Canada

glaxosmithkline consumer healthcare ulc - benzoyl peroxide - lotion - 4% - benzoyl peroxide 4% - keratolytic agents

United States - English - NLM (National Library of Medicine)

spa de soleil - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - purpose acne treatment for treatment of acne

United States - English - NLM (National Library of Medicine)

spa de soleil - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - purpose acne treatment for treatment of acne

Australia - English - Department of Health (Therapeutic Goods Administration)

dynamx australia t/a macmed healthcare - 11093 - cushion, - asklesante cushioning devices are used to provide support and comfort and/or assist the user to fulfil a functional requirement, e.g. sitting, lying, walking, toiletting or nursing. in some cases it may also assist to alleviate pressure to body parts (and development of pressure or bed sores) when the patient is immobilized for longer periods of time or has little body fat. the cushions are typically designed to achieve an intended purpose and will be made to suit that particular anatomical body part or supportive function. materials of construction and size and shaped are varied by specific intended purpose.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113), cobicistat (unii: lw2e03m5pg) (cobicistat - unii:lw2e03m5pg) - darunavir 800 mg - prezcobix ® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv-1) infection in treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions (v11i, v32i, l33f, i47v, i50v, i54l, i54m, t74p, l76v, i84v, l89v). prezcobix is contraindicated in patients receiving the following co-administered drugs prezcobix is contraindicated in patients receiving the following co-administered drugs [see drug interactions (7.3) and clinical pharmacology (12.3)]. - alpha 1-adrenoreceptor antagonist: alfuzosin - anticonvulsants: carbamazepine, phenobarbital, phenytoin - anti-gout: colchicine, in patients with renal and/or hepatic impairment - antimycobacterial: rifampin - antipsychotics: lurasidone, pimozide - cardiac disorders: dronedarone, ivabradine, ranolazinecardiac disorders: dronedarone, ivabradine, ranolazine - ergot derivatives, e.g. dihydroergotamine, ergotamine, methylergonovine - gi motility agent: cisapride - he

United States - English - NLM (National Library of Medicine)

clinigen healthcare ltd - dexrazoxane hydrochloride (unii: 5346058q7s) (dexrazoxane - unii:048l81261f) - dexrazoxane 500 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

neurotek pty ltd -